PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...
DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a ...
Irish Examiner on MSN19h
I was shocked to be diagnosed with triple-negative breast cancer in my 40sCiara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative ...
Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...
It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...
hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...
Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...
An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback